Vagus nerve stimulation and the ketogenic diet

Neurologic Clinics

Volumn 19, Issue 2, 2001, Pages 371-407

  Wheless, James W ^a   Baumgartner, James ^a   Ghanbari, Caroline ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

BRAIN SURGERY; CLINICAL TRIAL; COGNITIVE DEFECT; DIET THERAPY; DISEASE CONTROL; EPILEPSY; HUMAN; NONHUMAN; PATIENT COMPLIANCE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT FAILURE; VAGUS NERVE STIMULATION;

EID: 0035010550     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70023-2     Document Type: Article

References (237)

1. Considerations for safety with chronically implanted nerve electrodes
2. Histologic and physiologic evaluation of electrically stimulated peripheral nerve: Considerations for the selection of parameters
3. Diseases of the nervous system in childhood
4. Vagus nerve stimulation in epileptic encephalopathies
5. Effects of unbalanced diets on cerebral glucose metabolism in the adult rat
6. An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: Rationale, technique, and outcome
7. Epilepsy, vagal nerve stimulation by the NCP System, mortality, and sudden, unexpected, unexplained death
8. Epilepsy, vagal nerve stimulation by the NCP System, mortality, and sudden, unexpected, unexplained death
9. An animal model for the ketogenic diet
10. Early experience with vagus nerve stimulation for the treatment of epilepsy: Cardiac complications
11. Complications of the ketogenic diet
12. The ketogenic diet
13. Ketogenic diet treatment of epilepsy in adults
14. The ketogenic diet and its use
15. Epilepsy in adults: Results of treatment by ketogenic diet in one hundred cases
16. The ketogenic treatment of epilepsy
17. Corpus callosotomy
18. Drug treatment of epilepsy: Outlines, criticism and perspectives
19. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures
20. Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years
21. Vagus nerve stimulation for treatment of partial seizures. 1: A controlled study of effect on seizures
22. Treatment of acquired epileptic aphasia with the ketogenic diet
23. Bible
24. Glucose transporter type 1 deficiency: A study of two cases with video-EEG
25. Cost-benefit of vagus nerve stimulation for refractory epilepsy
26. Path analysis shows that increasing ketogenic ratio, but not beta-hydroxybutyrate, elevates seizure threshold in the rat
27. A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat
28. A ketogenic diet has different effects upon seizures induced by maximal electroshock and by pentylenetetrazole infusion
29. Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet
30. Epilepsy in childhood and adolescence
31. The mechanism of the ketogenic diet in epilepsy
32. Antiepileptic drugs
33. Starvation
34. Antiepileptic drug therapy: When is epilepsy truly intractable
35. Clinical administration of new antiepileptic drugs: An overview of safety and efficacy
36. Afferent vagal stimulation: Neurographic correlates of induced EEG synchronization and desynchronization
37. Cortical and subcortical patterns of response to afferent vagal stimulation
38. Enhanced recognition memory following vagus nerve stimulation in human subjects
39. Chronic stimulation of the left vagus nerve: Cognitive motor effects
40. Chronic stimulation of the left vagus nerve in epilepsy: Balance effects
41. Epilepsy in children: With particular reference to the ketogenic diet
42. Amino acid transmitters
43. 14C] acetoacetate into amino acids in rat brain in vivo
44. The rate of cerebral utilization of glucose, ketone bodies and oxygen: Comparative in vivo study of infant and adult rats
45. Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat
46. GABA and glycine
47. The effects of ketone bodies on glucose utilization
48. How to use other drugs (steroids) and the ketogenic diet
49. Chronic ketosis and cerebral metabolism
50. Starvation and seizures: Observations on the electroconvulsive threshold and cerebral metabolism of the starved adult rat
51. Ketotic hypoglycemia and the ketogenic diet
52. Glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures and developmental delay
53. New antiepileptic drugs
54. Management of seizure disorders: Selected aspects. Part II
55. The prognosis for seizure control in newly diagnosed epilepsy
56. Regulation of GABA level in rat brain synaptosomes: Fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies
57. Carbohydrate and alcohol content of 200 oral liquid medications for use in patients receiving ketogenic diets
58. The blood supply of vagus nerve in the human: Its implication in carotid endarterectomy, thyroidectomy and carotid arch aneurectomy
59. Epilepsy: Its treatment by the use of the ketogenic diet versus drugs
60. Emerging antiepileptic drugs
61. Reassessment: Vagus nerve stimulation for epilepsy
62. Social issues in epilepsy
63. Seizures decrease rapidly after fasting
64. The efficacy of the ketogenic diet 1998: A prospective evaluation of intervention in 150 children
65. Fasting as a method for treating epilepsy
66. Medication cost reduction in children on the ketogenic diet: Data from a prospective study
67. Induction processes in blood-brain transfer of ketone bodies during starvation
68. Therapeutic effects of a ketogenic diet in Rett syndrome
69. Disordered mineral metabolism produced by ketogenic diet therapy
70. Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects
71. Neurochemical effects of vagus nerve stimulation in humans
72. Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial
73. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation
74. Ketogenic diet in the treatment of refractory epilepsy in childhood
75. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967
76. Ketone bodies are selectively used by individual brain regions
77. Regional brain utilization of ketone bodies
78. Effects of ketosis on glucose flux in children and adults
79. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: A randomized comparative monotherapy trial
80. Comparative efficacy and toxicity of phenytoin, carbamazepine, and valproate in adults and children with newly diagnosed previously untreated epilepsy: A randomized long-term trial
81. Vagus nerve stimulation (VNS) in children: Quality of life and safety
82. Adjunctive treatment in Lennox-Gastaut syndrome using vagal nerve stimulation
83. The treatment of epilepsy in childhood: Five years' experience with the ketogenic diet
84. Results of fifteen years' experience with the ketogenic diet in the treatment of epilepsy in children
85. Eight years' experience with the ketogenic diet in the treatment of epilepsy
86. Ten years' experience in the treatment of epilepsy with the ketogenic diet
87. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy
88. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children
89. Urolithiasis associated with the ketogenic diet
90. Treatment of refractory partial seizures: Preliminary results of a controlled study
91. Vagal nerve stimulation: Updated experience in 60 pediatric patients
92. Left vagus nerve stimulation in children with refractory epilepsy: An update
93. Use of ketogenic diet in epilepsy in childhood
94. Optic neuropathy in ketogenic diet
95. Ketonemia and seizures: Metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy
96. The problem of intractability: The continuing need for new medical therapies in epilepsy
97. Results of treatment of recurring convulsive attacks of epilepsy
98. Efficacy of the ketogenic diet for intractable seizure disorders: Review of 58 cases
99. 15O blood flow imaging
100. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation
101. Developmental changes of cerebral ketone body utilization in human infants
102. Vagus nerve stimulation for medication: Resistant generalized epilepsy
103. Vagus nerve stimulation for symptomatic generalized epilepsy: A pilot study
104. Fasting studies in cerebrospinal fluid and blood in children with epilepsy of unknown origin
105. Vagus nerve stimulation for complex partial seizures: Surgical technique, safety, and efficacy
106. An improved ketogenic diet for treatment of epilepsy
107. Stimulation of the phrenic nerve as a complication of vagus nerve pacing in a patient with epilepsy
108. Ketogenic diet in the treatment of epilepsy
109. Studies in epilepsy, VIII: The clinical effect of fasting
110. Unexpected places: How did vagus nerve stimulation become a treatment for epilepsy?
111. Brief bursts of pulse stimulation terminate after discharges caused by cortical stimulation
112. Ketogenic diet and epilepsy
113. Ketogenic diet in the treatment of childhood epilepsy
114. Feasibility and safety of vagal stimulation in monkey model
115. Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures
116. Vagus nerve stimulation in 16 children with refractory epilepsy
117. Aspiration: A potential complication to vagus nerve stimulation
118. The ketogenic diet
119. Brain pH in humans treated with the ketogenic diet
120. The new antiepileptic drugs: A systematic review of their efficacy and tolerability
121. Efficacy and adverse effects of established and new antiepileptic drugs
122. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures
123. A comparison of valproate with carbamazepine for the treatment of complex partial and secondary generalized tonic-clonic seizures in adults
124. Prognosis for total control of complex partial and secondarily generalized tonic-clonic seizures
125. Integration of metabolism and the provision of tissue fuels
126. Oxidation of fatty acids: Ketogenesis
127. Amino acid neurotransmitters
128. Suppression of interictal spikes and seizures by stimulation of the vagus nerve
129. Vagus nerve stimulation for intractable epilepsy: A review
130. Epilepsy in children
131. Pyruvate dehydrogenase complex deficiency associated with brain dysgenesis: Response of lactic acidemia to a ketogenic diet
132. The role of mesencephalic and thalamic arousal systems in experimental seizures
133. Mechanism of anticonvulsant action of ketogenic diet
134. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy
135. Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model
136. Left vagal nerve stimulation in children with medically refractory epilepsy
137. Left vagal nerve stimulation in children with refractory epilepsy: Preliminary observations
138. Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides
139. Effects of reducing stimulation intervals on antiepileptic efficacy of vagus nerve stimulation (VNS)
140. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve
141. Epilepsy: Treatment of institutionalized adult patients with a ketogenic diet
142. Brain metabolism during fasting
143. 31P spectroscopic imaging at 4.1 T
144. Vagal nerve stimulation in epileptic encephalopathies
145. Efficacy and adverse effects of antiepileptic drugs
146. Seizures and epilepsy in infancy and childhood
147. Standard approach to antiepileptic drug treatment in the United States
148. Antiepileptic drug therapy in the United States: A review of clinical studies and unmet needs
149. Utilization of new antiepileptic drugs in children
150. Adverse effects of antiepileptic drugs
151. Utilization of glutamine and of TCA cycle constituents as precursors for transmitter glutamate and GABA
152. Prevention of intractable seizures by intermittent vagal stimulation in humans: Preliminary results
153. Cerebral arterio-venous difference of acetoacetate and d-beta-hydroxybuturate in children
154. The ketogenic diet in epilepsy
155. A receptors activation
156. Alternative epilepsy therapies: The ketogenic diet, immunoglobulins, and steroids
157. The present status of the ketogenic diet
158. Vagus nerve stimulation for treatment of partial seizures. 2: Safety, side effects, and tolerability
159. Surgical technique for implantation of the neurocybernetic prosthesis
160. GABA levels are increased in the hippocampus of mature mice fed a ketogenic diet
161. Conversion of amino acids to specialized product
162. Mitochondrial fatty acid oxidation disorders
163. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet
164. Early biochemical and EEG correlates of the ketogenic diet in children with atypical absence epilepsy
165. Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study
166. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation
167. Some aspects of prognosis in the epilepsies: A review
168. Metabolic and endocrine aspects of the ketogenic diet
169. Vagus nerve stimulation
170. Chronic stimulation of the left vagal nerve in children: Effect on swallowing
171. Vagal nerve stimulation: Experience in 60 children
172. Ketogenic diets in the treatment of epilepsy: Short-term clinical effects
173. Metabolic effects of three ketogenic diets in the treatment of severe epilepsy
174. Mechanisms underlying the antiepileptic efficacy of the ketogenic diet
175. Heart period variability during vagal nerve stimulation
176. 1H-MRS in patients with epilepsy controlled by ketogenic diet
177. Acquired epileptiform opercular syndrome: A second case report, review of the literature, and comparison to the Landau-Kleffner syndrome
178. Overview of the safety of newer antiepileptic drugs
179. The ketogenic diet for intractable epilepsy in adults: Preliminary results
180. Metabolism of ketone bodies by the brain
181. Corpus callosotomy for medically intractable seizures
182. Temporal lobectomy for refractory epilepsy
183. Animal models of the ketogenic diet: What have we learned, what can we learn?
184. Electrophysiological observations in hippocampal slices from rats treated with the ketogenic diet
185. Progression in mesial temporal lobe epilepsy
186. Efficacy of the ketogenic diet in children under 2 years of age
187. The ketogenic diet: 1997
188. Infantile phosphofructokinase deficiency with arthrogryposis: Clinical benefit of a ketogenic diet
189. Vagus nerve stimulation induces a sustained anticonvulsant effect
190. The ketogenic diet in the treatment of idiopathic epilepsy
191. Ventricular asystole during vagus nerve stimulation for epilepsy in humans
192. An implantable neurocybernetic prosthesis system
193. The implantable neurocybernetic prosthesis system
194. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures
195. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission
196. Chronic valproate administration reduces fasting ketonemia in children
197. Valproate causes metabolic disturbance in normal men
198. Anticonvulsant properties of the ketogenic diet in mice
199. Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures
200. Treatment of epilepsy by stimulation of the vagus nerve
201. Surgical outcome for neocortical (extrahippocampal) focal epilepsy
202. Clinical efficacy of the ketogenic diet
203. A multi-center study of the efficacy of the ketogenic diet
204. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius
205. Observations on fasting and diets in the treatment of Epilepsy
206. The epilepsy diet treatment: An introduction to the ketogenic diet, book review
207. The ketogenic diet: Fa(c)t or fiction
208. Vagus Nerve Stimulation (VNS) in children: Efficacy
209. Vagus nerve stimulation for intractable epilepsy: A series of 50 patients operated on at one center and with a comparison of two cycle types
210. Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: Results of treatment with a ketogenic diet
211. Vagal stimulation for control of complex partial seizures in medically refractory epileptic patients
212. The effects of ketonuria on the course of epilepsy
213. Ketosis and the ketogenic diet: Their application to treatment of epilepsy and infections of the urinary tract
214. Epilepsy in childhood: III. Results with the ketogenic diet
215. Ketone body metabolism during development
216. Antiepileptic drugs, the ketogenic diet: Mechanism of anticonvulsant action
217. Effects of vagal stimulation on experimentally induced seizures in rats
218. Vagus nerve stimulation for control of epilepsy in humans: Suggested new parameters
219. Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: Use of a cuff electrode for stimulating and recording
220. Inhibition of experimental seizures in canines by repetitive vagal stimulation
221. The effect of vagal afferent stimulation on the EEG pattern of the cat